Replies to post #232939 on Innovation Pharmaceuticals Inc (IPIX)

[groton68]

Aspire structured this deal in an advantaged way for themselves. It was the only game in town.

[NickAidenNY]

My opinion and outlook:

As I have said in the past a few times, I feel the overall play here is a complete buyout for all of IPIX’s assets but would only happen if Prurisol shows the be affective and marketable. I feel a major pharmaceutical company has first right of refusal on a complete buyout offer. If Prurisol does not meet it’s primary endpoint then we are looking at BTD determination before partnership deal for B indications singularly or as a whole.

Aspire deal allows for IP to have all the necessary funds to exist while either one of these scenarios plays out.

GTLA

[DaubersUP]

IMO. It was last day of Q. Needed to add cash to Q. It sends a message to the investment community, as the price was .38 that Aspire felt that was the lowest it should be. Overall, I think this move was one of the most brilliant PR related moves by ipix. It will spark excitement for the next 3 months. The milestones will add an additional PR each time one is hit.....double whammy. It allows a stair step price security for us shareholders. Leo dropping the data lock hours into the trading day was beautiful. He knows they will reach all 3 milestones. IMO.

Also, that 2 million at .38 could have been to pay the final bill for cro phase 2b, and therefore they locked data.

The next 3 months will be exciting as we climb back to where we should be in high dollars. IMO.